Australian healthtech Everlab has raised AU$65m in Series A funding. The oversubscribed round was led by Airtree Ventures (AU), with participation from global investors including Plural (EU) and existing investors Left Lane Capital (US) and b2venture (EU), alongside angel investors including Australian Test captain Pat Cummins.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260616811872/en/
Everlab founding team (L-R): Dr. Steven Lu, Sam Kothari, Anshul Jain, Marc Hermann
The round marks Everlab’s evolution into a complete care platform, transforming the primary care system built to treat illness into one built to prevent it. Today, patients navigate fragmented point solutions that don’t connect: legacy providers whose records live in isolation, transactional telehealth appointments with no continuity, and wearables that produce surface-level insights without clinical follow-through.
Everlab’s digital app organizes diagnostics, doctors, specialists, prescriptions and continuous AI care in one place, giving patients a longitudinal view of their health for the first time. The platform integrates with 1,850+ health provider locations, 180+ active clinicians and 30+ wearable devices, and processes more than 200,000 health reports per month.
“The existing system is fragmented, handing patients between providers and hoping the information follows,” says Marc Hermann, Co-founder and CEO of Everlab. “We built Everlab to hold the full picture, surface health blind spots and coordinate what needs to happen next—from targeted screenings to personalized health plans—helping more people live longer, healthier lives.”
Founded in Melbourne in 2023, Everlab has completed 40,000+ consultations supporting 20,000 individual patients and major corporate partners, including Boston Consulting Group, BHP and Bain & Company. Having processed over 21 million biomarker test results, more than 25% of members have had findings flagged that have not been identified through the existing healthcare system.
“Our patient base reflects the broader Australian population, and earning their trust to hold decades of their health data is the foundation everything else runs on,” says Dr Steven Lu, the company’s Chief Medical Officer. “Our goal is to cut a new path for primary care globally, proving that deep patient engagement and first-class preventative care don’t just improve outcomes, it reduces the lifetime cost of care for everyone.”
The raise marks Everlab’s move into the $10 trillion global consumer healthcare market, starting with the UK. The funding will be used to strengthen its clinical and technology infrastructure and accelerate its global rollout.
“The more time we spent with the Everlab team, the more convinced we became that they’re building a generational health business. With a world-class product and growing at a pace we rarely see, they’re already the leader in Australia and we’re backing them to do the same globally,” says John Henderson, Partner at Airtree.
Carina Namih, Partner at Plural, added: “Every company that has tried to own the patient journey has ended up either selling doctor time by the minute or reselling lab tests with thin margins. Everlab is building the layer above both: the system that interprets and coordinates your health data over time rather than capturing a single transaction. The fact that they’ve already proven their model operationally in Australia, at scale, is what convinced me this is the version that genuinely works.”
About Everlab
Everlab is a healthtech company providing preventative, personalized healthcare through a data-driven and AI-enabled model. By combining advanced diagnostics, clinician-led care and technology, Everlab helps detect and prevent disease risk earlier.
Founded in Melbourne in 2023, Everlab operates across Australia and New Zealand, supporting both individuals and organizations through preventative healthcare programs.
Everlab’s mission is to maximize healthspan at the lowest lifetime cost, empowering people to live their richest and most meaningful lives. For more information, visit www.everlab.com.au.
View source version on businesswire.com: https://www.businesswire.com/news/home/20260616811872/en/
Media gallery
